CA-CHARGEPOINT
19.6.2024 09:01:31 CEST | Business Wire | Press release
ChargePoint (NYSE: CHPT), a leading provider of networked charging solutions for electric vehicles (EVs), today announced a suite of updates and additions to its be.ENERGISED platform, a leading European software solution for the management of charging networks and e-mobility services at scale.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240619736580/en/
(Photo: Business Wire)
be.ENERGISED now manages over 900 models of charging stations from more than 100 manufacturers. New features, offerings and enhancements include:
- The first payment terminal to meet the new OCPI v2.2.1 Direct Payment Module industry standards and comply with the recently instated AFIR (Alternative Fuel Infrastructure Regulation).
- eMobility Service Providers (eMSPs) can use the solutions’ roaming network to give their drivers selected access to more than 750,000 stations across the whole of Europe. Charge Point Operators (CPOs) can easily make their stations available to the public and all drivers on the major eMSPs via be.ENERGISED COMMUNITY roaming agreements in just a few clicks of a mouse.
- In addition, the CP6000 - ChargePoint’s most flexible and serviceable global AC EV charging solution - is available from this week on the be.ENERGISED platform to select customers. The CP6000 is designed for scalability, flexibility, and reliability, offering reliable AC charging for 1 or 3 phase power at an adaptable output of 3.7 to 22kw per port.
ChargePoint’s be.ENERGISED platform boasts consolidated services for CPOs and eMSPs, including VAT handling, automated invoicing, streamlining financial operations for multinational charging providers. With over 85,000 charging ports and 30 million charging sessions per month, be.ENERGISED’s scale and experience are unparalleled in the industry. The software offers an end-to-end solution capable of addressing every aspect of the charging process, providing unmatched flexibility and modularity to cater to all use cases.
The EV charging landscape is rapidly evolving, with CPOs and eMSPs becoming far more sophisticated, often relying on many makes of chargers and hundreds of software integrations with partners. As their expertise deepens, so do their needs, transforming from initial solutions into intricate networks which require robust protection and management. This shift signifies a move from the early days of greenfield projects to the current “brownfield” environment, where existing charger investments must be futureproofed alongside the implementation of new infrastructure. Though new chargers are constantly being brought online, ensuring a reliable network requires legacy hardware running just as well as the newest installations. All of this underscores the need for a well-rounded, adaptable software solution such as be.ENERGISED.
“A new set of market demands necessitates even the most advanced charger management platforms to deliver innovative features for the future,” said Andreas Blin, Director for Service Provision at ChargePoint. “A leader in the market for more than a decade, be.ENERGISED meets the challenges charging businesses face, ensuring that both new and existing infrastructure can excel in an ever more dynamic environment.”
Since acquiring be.ENERGISED three years ago, ChargePoint has continued to foster and develop the product to ensure market leadership while delivering bespoke solutions for international customers. be.ENERGISED is now the most flexible and comprehensive solution on the market, and one built for the future without forgetting about the past.
To learn more about ChargePoint’s be.ENERGISED platform, please click here or visit the ChargePoint stand B6.111Hall B6 at the Power2Drive charging infrastructure exposition in Munich held June 19-21st.
About ChargePoint Holdings, Inc.
ChargePoint is creating a new fuelling network to move people and goods on electricity. Since 2007, ChargePoint has been committed to making it easy for businesses and drivers to go electric with one of the largest EV charging networks and a comprehensive portfolio of charging solutions. The ChargePoint cloud subscription platform and software-defined charging hardware are designed to include options for every charging scenario from home and multifamily to workplace, parking, hospitality, retail, and transport fleets of all types. Today, one ChargePoint account provides access to hundreds-of-thousands of places to charge in North America and Europe. For more information, visit the ChargePoint pressroom, the ChargePoint Investor Relations site, or contact the ChargePoint North American or European press office or Investor Relations.
CHPT-IR
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240619736580/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Kubota Vision Inc. Signs Supply and Licensing Agreement with Laboratoires KÔL for Stargardt Disease Treatment Candidate Under Compassionate Use4.5.2026 17:16:00 CEST | Press release
Kubota Vision Inc. (“Kubota Vision”), a wholly-owned subsidiary of Kubota Pharmaceutical Holdings Co., Ltd. (Minato-ku, Tokyo, Japan) announced signing of a Supply and Licensing Agreement with Laboratoires KÔL (Clermont-Ferrand, France) for the provision of a Stargardt disease (STGD1) treatment candidate under compassionate use authorization. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260414590785/en/ The purpose of this Agreement is for Kubota Vision and KÔL to collaborate on providing “Emixustat” for treatment of Stargardt Disease (STGD1) through compassionate use authorization in France. Kubota Vision will exclusively manufacture and supply Emixustat final products to KÔL and KÔL will have exclusive rights to distribute Emixustat in France under compassionate use access. Ryo Kubota, Chairman, President, and CEO of Kubota Pharmaceutical Holdings, stated, “We are extremely pleased to enter into this Agreement with Labor
Incentive Market Set to Surpass $80B by 2030s — IMA Launches Tools to Help the Industry Keep Pace4.5.2026 16:28:00 CEST | Press release
With combined business spend on loyalty, employee recognition, and channel incentives projected to exceed $80 billion by the 2030s, the incentive industry is entering a period of rapid scale and strategic pressure. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260422729016/en/ In response, the Incentive Marketing Association (IMA) launched a new suite of resources designed to help incentive professionals navigate an environment that’s becoming more specialized, fragmented, and central to business performance. “It’s not just more money coming in—it’s more complexity,” said Vince Chiofolo, President of the Incentive & Engagement Solution Providers (IESP). “Buyers are demanding programs that evolve fast, integrate deeply, and feel personal at scale. These new tools were built for that.” IMA’s Suite of Tools Includes: New Industry Report — Inside the Incentive Buyer’s Mind Drawn from insights of 50+ program owners, the report f
Tigo Energy Breaks Global Growth Benchmark; Boosts U.S. Energy Feature in Predict+4.5.2026 15:00:00 CEST | Press release
Advanced energy prediction platform adds real-time energy pricing for North American Independent System Operator (ISO) customers, accelerates meters-connected growth. Tigo Energy, Inc. (NASDAQ: TYGO) (“Tigo” or “Company”), a leading provider of intelligent solar and energy solutions, today announced that the Predict+ platform now offers integrated real-time spot market pricing for ISO customers in the United States. Predict+ provides utilities with deep insights into grid demand, renewable generation, and energy market dynamics, enhancing the precision, scalability, and robustness of energy forecasting to up to 97.5% accuracy through machine learning and artificial intelligence. For energy providers, Predict+ helps streamline operations, reduce volatility, and maximize performance. Predict+ empowers utility operators to adapt to real-world demand challenges when balancing renewable and baseload generation sources, particularly during extreme weather events and market disruptions. On th
Airship Announces 2026 Elevate Customer Experience Award Winners4.5.2026 15:00:00 CEST | Press release
Southwest Airlines, The Economist, and OneFootball among brands recognized at Elevate’26 Customer Experience Summit for setting the standard in mobile-first and AI-centered customer experiences Airship, the mobile-first customer experience company, today announced the winners of the 2026 Elevate Customer Experience Awards. Global brand leaders from The Economist, Southwest Airlines, and OneFootball were among those honored at the Elevate’26 Customer Experience Summit. The Elevate Awards spotlight global companies that have developed exceptional mobile-first customer experiences for their customers, created innovative campaigns, leveraged AI agents to reach new levels of productivity, and achieved real business results. "Evolving mobile-first consumer behaviors and unprecedented advancements in AI are driving a seismic shift that is reshaping how brands interact with their customers," said Brett Caine, CEO, Airship. "The 2026 Elevate Award winners aren’t just adapting, they’re leading t
Alnylam to Present New Analyses at Heart Failure 2026 Underscoring Consistent Clinical Profile of Vutrisiran in ATTR-CM4.5.2026 14:30:00 CEST | Press release
Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced it will present new data analyses for vutrisiran in patients with the cardiomyopathy of wild-type or hereditary transthyretin-mediated amyloidosis (ATTR-CM) at Heart Failure 2026, a scientific congress of the European Society of Cardiology, taking place May 9-12, 2026, in Barcelona, Spain. ATTR-CM is a heterogeneous and rapidly progressive disease, and patients often present with complex clinical profiles. At Heart Failure 2026, Alnylam will present multiple new analyses from the Phase 3 HELIOS-B study of vutrisiran, which continue to support its use as a first-line treatment for patients with ATTR-CM, and further characterize its clinical profile across patients with a high disease burden, and in the context of concomitant therapies. Vutrisiran is the first and only transthyretin (TTR) silencer for ATTR-CM that delivers rapid knockdown of TTR at the source. Additional analyses being pr
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
